Tag: Chugai Pharmaceutical

January 4, 2017

Roche Launches cobas® c 513 analyzer and HbA1c Gen. 3 assay

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its new dedicated, high-throughput HbA1c testing solution, the cobas c 513...
October 5, 2016

Chugai's ACTEMRA/RoACTEMRA Receives Breakthrough Therapy Designation from FDA

Chugai Pharmaceutical announced that the US Food and Drug Administration has granted Breakthrough Therapy Designation to ACTEMRA®/RoACTEMRA® (tocilizumab), a Chugai...
October 4, 2016

Chugai's Alecensa Receives Breakthrough Therapy Designation from FDA

Chugai Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for the first-line...
September 30, 2016

US FDA Approves TAGRISSO® (osimertinib) Blood-Based T790M Companion Diagnostic Test

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved a blood-based companion diagnostic for TAGRISSO® (osimertinib).
September 29, 2016

Roche's Harmony® Prenatal Test Receives CE Mark

Roche now offers the micro-array based Harmony IVD kit and Ariosa Cell-Free DNA System software to laboratories outside the US...